Assets
| Type | Time | Amount | Unit |
|---|---|---|---|
| ifrs-full:Assets | 2016-12-31 | 97539000000 | vDKK |
| ifrs-full:Assets | 2015-12-31 | 91799000000 | vDKK |
Revenue
| Type | Start date | End date | Amount | Unit |
|---|
XML
See the xml submitted here:
XML: http://regnskaber.virk.dk/09765242/ZG9rdW1lbnRsYWdlcjovLzAzLzgwLzNiL2FjLzU5LzU1OGMtNDA2YS1iY2M0LTFjMzY4ZmUwNmRkOA.xml
Separator
The full data:
<?xml version="1.0" encoding="UTF-8"?><!-- Version: 1.1.668.0 --><!-- Document created: 28-03-2017 14:08:44 --><!-- Created by: XBRL Wizard, EasyX --><xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:entry03-ifrs-dk_2014-12-20="http://xbrl.dcca.dk/ifrs-dk/entry03-ifrs-dk_2014-12-20" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2014-03-05/ifrs-full" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:info="http://xbrl.iasb.org/info" xmlns:ifrs-mc="http://xbrl.ifrs.org/taxonomy/2014-03-05/ifrs-mc" xmlns:rol_ifrs-dk_105.00_2014-12-20="http://xbrl.dcca.dk/role/ifrs-dk/rol_ifrs-dk_105.00_2014-12-20" xmlns:tch="http://xbrl.dcca.dk/tch" xmlns:gen="http://xbrl.org/2008/generic" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:entry="http://entry" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:reference="http://xbrl.org/2008/reference" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:cmn="http://xbrl.dcca.dk/cmn" xmlns:label="http://xbrl.org/2008/label" xmlns:rol_ifrs-dk_110.00_2014-12-20="http://xbrl.dcca.dk/role/ifrs-dk/rol_ifrs-dk_110.00_2014-12-20" xmlns:rol_ifrs-dk_210.00_2014-12-20="http://xbrl.dcca.dk/role/ifrs-dk/rol_ifrs-dk_210.00_2014-12-20" xmlns:rol_ifrs-dk_310.00_2014-12-20="http://xbrl.dcca.dk/role/ifrs-dk/rol_ifrs-dk_310.00_2014-12-20" xmlns:rol_ifrs-dk_330.00_2014-12-20="http://xbrl.dcca.dk/role/ifrs-dk/rol_ifrs-dk_330.00_2014-12-20" xmlns:rol_ifrs-dk_420.00_2014-12-20="http://xbrl.dcca.dk/role/ifrs-dk/rol_ifrs-dk_420.00_2014-12-20" xmlns:rol_ifrs-dk_520.00_2014-12-20="http://xbrl.dcca.dk/role/ifrs-dk/rol_ifrs-dk_520.00_2014-12-20" xmlns:rol_ifrs-dk_610.00_2014-12-20="http://xbrl.dcca.dk/role/ifrs-dk/rol_ifrs-dk_610.00_2014-12-20" xmlns:rol_ifrs-dk_710.00_2014-12-20="http://xbrl.dcca.dk/role/ifrs-dk/rol_ifrs-dk_710.00_2014-12-20" xmlns:rol_ifrs-dk_8NN.NN_2014-12-20="http://xbrl.dcca.dk/role/ifrs-dk/rol_ifrs-dk_8NN.NN_2014-12-20" xmlns:rol_dim="http://xbrl.ifrs.org/role/ifrs/dimensions" xmlns:ifrs-dk="http://xbrl.dcca.dk/ifrs-dk-cor_2014-12-20" xmlns:entry-sob="http://xbrl.dcca.dk/entry-sob" xmlns:sob="http://xbrl.dcca.dk/sob" xmlns:rol_sob_300.00_2014-12-20="http://xbrl.dcca.dk/role/sob/rol_sob_300.00_2014-12-20" xmlns:cmn_rol="http://archprod.service.eogs.dk/taxonomy/20161220/cmn_rol.xsd" xmlns:entry-mrv="http://xbrl.dcca.dk/entry-mrv" xmlns:gsd="http://xbrl.dcca.dk/gsd" xmlns:dst="http://xbrl.dcca.dk/dst" xmlns:fsa="http://xbrl.dcca.dk/fsa" xmlns:ifrs-temp-entry="http://ifrs-temp-entry" xmlns:tax="http://xbrl.dcca.dk/tax" xmlns:mrvcsr="http://xbrl.dcca.dk/mrvcsr" xmlns:mrv="http://xbrl.dcca.dk/mrv" xmlns:rol_mrv_2014-12-20="http://xbrl.dcca.dk/role/mrv/rol_mrv_2014-12-20" xmlns:rol_ps_mc_2014-03-05="http://xbrl.ifrs.org/role/ifrs/rol_ps_mc_2014-03-05" xmlns:entry-gsd="http://xbrl.dcca.dk/entry-gsd" xmlns:ca="http://xbrl.org/2008/assertion/consistency" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:variable="http://xbrl.org/2008/variable" xmlns:xfi="http://www.xbrl.org/2008/function/instance" xmlns:cf="http://xbrl.org/2008/filter/concept" xmlns:valm="http://xbrl.org/2010/message/validation" xmlns:ea="http://xbrl.org/2008/assertion/existence" xmlns:rol_gsd_000.00_2014-12-20="http://xbrl.dcca.dk/role/gsd/rol_gsd_000.00_2014-12-20" xmlns:validation="http://xbrl.org/2008/validation" xmlns:formula="http://xbrl.org/2008/formula" xmlns:msg="http://xbrl.org/2010/message" xmlns:va="http://xbrl.org/2008/assertion/value" xmlns:entry-arr="http://xbrl.dcca.dk/entry-arr" xmlns:arr="http://xbrl.dcca.dk/arr" xmlns:rol_arr_1NN.NN_2016-12-20="http://xbrl.dcca.dk/role/arr/rol_arr_1NN.NN_2016-12-20" xmlns:rol_ifrs-dk_510.00_2014-12-20="http://xbrl.dcca.dk/role/ifrs-dk/rol_ifrs-dk_510.00_2014-12-20" xsi:schemaLocation="http://xbrl.org/2006/xbrldi http://www.xbrl.org/2006/xbrldi-2006.xsd">
<link:schemaRef xlink:type="simple" xlink:href="http://archprod.service.eogs.dk/taxonomy/20161220/ifrs/entry-ifrs-dk_03_IS-ByFunction_SFP-CurrentNoncurrent_OCI-BeforeTax_CF-IndirectMethod_2016-12-20.xsd"/>
<xbrli:context id="ctx1">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2016-01-01</xbrli:startDate>
<xbrli:endDate>2016-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="ctx2">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2015-01-01</xbrli:startDate>
<xbrli:endDate>2015-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="ctx3">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2014-01-01</xbrli:startDate>
<xbrli:endDate>2014-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="ctx4">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2016-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="ctx5">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2015-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="ctx6">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2016-01-01</xbrli:startDate>
<xbrli:endDate>2016-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInOperatingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>0</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx7">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2015-01-01</xbrli:startDate>
<xbrli:endDate>2015-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInOperatingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>1</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx8">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2014-01-01</xbrli:startDate>
<xbrli:endDate>2014-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInOperatingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>2</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx9">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2016-01-01</xbrli:startDate>
<xbrli:endDate>2016-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInOperatingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>3</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx10">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2015-01-01</xbrli:startDate>
<xbrli:endDate>2015-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInOperatingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>4</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx11">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2014-01-01</xbrli:startDate>
<xbrli:endDate>2014-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInOperatingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>5</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx12">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2016-01-01</xbrli:startDate>
<xbrli:endDate>2016-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInInvestingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>0</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx13">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2015-01-01</xbrli:startDate>
<xbrli:endDate>2015-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInInvestingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>1</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx14">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2014-01-01</xbrli:startDate>
<xbrli:endDate>2014-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInInvestingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>2</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx15">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2016-01-01</xbrli:startDate>
<xbrli:endDate>2016-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInInvestingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>3</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx16">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2015-01-01</xbrli:startDate>
<xbrli:endDate>2015-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInInvestingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>4</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx17">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2014-01-01</xbrli:startDate>
<xbrli:endDate>2014-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInInvestingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>5</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx18">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2016-01-01</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="ctx19">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2015-01-01</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="ctx20">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2014-01-01</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="ctx21">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2014-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="ctx22">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2016-01-01</xbrli:startDate>
<xbrli:endDate>2016-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="cmn:IdentificationOfAuditorDimension">
<cmn:auditorIdentificer>0</cmn:auditorIdentificer>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx23">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2016-01-01</xbrli:startDate>
<xbrli:endDate>2016-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="cmn:IdentificationOfAuditorDimension">
<cmn:auditorIdentificer>1</cmn:auditorIdentificer>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx24">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2016-01-01</xbrli:startDate>
<xbrli:endDate>2016-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="cmn:IdentificationOfMemberOfExecutiveBoardAxis">
<cmn:memberOfBoardIdentifier>0</cmn:memberOfBoardIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx25">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2016-01-01</xbrli:startDate>
<xbrli:endDate>2016-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="cmn:IdentificationOfMemberOfExecutiveBoardAxis">
<cmn:memberOfBoardIdentifier>1</cmn:memberOfBoardIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx26">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2016-01-01</xbrli:startDate>
<xbrli:endDate>2016-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="cmn:IdentificationOfMemberOfExecutiveBoardAxis">
<cmn:memberOfBoardIdentifier>2</cmn:memberOfBoardIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx27">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2016-01-01</xbrli:startDate>
<xbrli:endDate>2016-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="cmn:IdentificationOfMemberOfExecutiveBoardAxis">
<cmn:memberOfBoardIdentifier>3</cmn:memberOfBoardIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx28">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2016-01-01</xbrli:startDate>
<xbrli:endDate>2016-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="cmn:IdentificationOfMemberOfSupervisoryBoardAxis">
<cmn:memberOfBoardIdentifier>0</cmn:memberOfBoardIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx29">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2016-01-01</xbrli:startDate>
<xbrli:endDate>2016-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="cmn:IdentificationOfMemberOfSupervisoryBoardAxis">
<cmn:memberOfBoardIdentifier>1</cmn:memberOfBoardIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx30">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2016-01-01</xbrli:startDate>
<xbrli:endDate>2016-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="cmn:IdentificationOfMemberOfSupervisoryBoardAxis">
<cmn:memberOfBoardIdentifier>2</cmn:memberOfBoardIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx31">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2016-01-01</xbrli:startDate>
<xbrli:endDate>2016-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="cmn:IdentificationOfMemberOfSupervisoryBoardAxis">
<cmn:memberOfBoardIdentifier>3</cmn:memberOfBoardIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx32">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2016-01-01</xbrli:startDate>
<xbrli:endDate>2016-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="cmn:IdentificationOfMemberOfSupervisoryBoardAxis">
<cmn:memberOfBoardIdentifier>4</cmn:memberOfBoardIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx33">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2016-01-01</xbrli:startDate>
<xbrli:endDate>2016-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="cmn:IdentificationOfMemberOfSupervisoryBoardAxis">
<cmn:memberOfBoardIdentifier>5</cmn:memberOfBoardIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx34">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2016-01-01</xbrli:startDate>
<xbrli:endDate>2016-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="cmn:IdentificationOfMemberOfSupervisoryBoardAxis">
<cmn:memberOfBoardIdentifier>6</cmn:memberOfBoardIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx35">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2016-01-01</xbrli:startDate>
<xbrli:endDate>2016-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="cmn:IdentificationOfMemberOfSupervisoryBoardAxis">
<cmn:memberOfBoardIdentifier>7</cmn:memberOfBoardIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx36">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2016-01-01</xbrli:startDate>
<xbrli:endDate>2016-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="cmn:IdentificationOfMemberOfSupervisoryBoardAxis">
<cmn:memberOfBoardIdentifier>8</cmn:memberOfBoardIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx37">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2016-01-01</xbrli:startDate>
<xbrli:endDate>2016-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="cmn:IdentificationOfMemberOfSupervisoryBoardAxis">
<cmn:memberOfBoardIdentifier>9</cmn:memberOfBoardIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx38">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">24256790</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2016-01-01</xbrli:startDate>
<xbrli:endDate>2016-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="cmn:IdentificationOfMemberOfSupervisoryBoardAxis">
<cmn:memberOfBoardIdentifier>10</cmn:memberOfBoardIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:unit id="vDKK">
<xbrli:measure>iso4217:DKK</xbrli:measure>
</xbrli:unit>
<xbrli:unit id="share">
<xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit>
<gsd:ReportingPeriodStartDate contextRef="ctx1">2016-01-01</gsd:ReportingPeriodStartDate>
<gsd:ReportingPeriodEndDate contextRef="ctx1">2016-12-31</gsd:ReportingPeriodEndDate>
<mrv:CorporateGovernanceReport contextRef="ctx1" xml:lang="en"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">GOVERNANCE STRUCTURE</td></tr><tr><td colspan="1">SHAREHOLDERS</td></tr><tr><td colspan="1">Shareholders have ultimate authority over the company and exercise their rights to make decisions at general meetings. At the annual general meeting, shareholders approve the annual report and any amendments to the companyâs Articles of Association. Shareholders also elect board members and the independent auditor.</td></tr><tr><td colspan="1">Resolutions can generally be passed by a simple majority. However, resolutions to amend the Articles of Association require two-thirds of the votes cast and capital represented, unless other adoption requirements are imposed by the Danish Companies Act.</td></tr><tr><td colspan="1">Novo Nordiskâs share capital is divided into A shares, which are not listed, and B shares, which are listed.* The A shares constitute 21% of the share capital and each A share carries 200 votes. The B shares constitute the rest of the capital and each B share carries 20 votes. The Danish company Novo A/S, which is wholly owned by the Novo Nordisk Foundation, holds all the A shares and, as of 31 December 2016, Novo A/S also holds approximately 8.1% of the B share capital, meaning that Novo A/S holds approximately 27.5% of the total share capital and 75% of the votes. The remaining B shares are held by a wide group of shareholders and, consequently, Novo A/S has the voting majority at the annual general meeting. However, all strategic and operational matters are solely decided by the Board of Directors and Executive Management of Novo Nordisk A/S. Read more about shares and capital structure on pp 44â45 and on novonordisk.com.</td></tr><tr><td colspan="1">BOARD OF DIRECTORS</td></tr><tr><td colspan="1">Novo Nordisk has a two-tier management structure consisting of the Board of Directors and Executive Management. The two bodies are separate, and no one serves as a member of both.</td></tr><tr><td colspan="1">The Board of Directors determines the companyâs overall strategy and follows up on its implementation, supervises the performance, ensures adequate management and organisation and, as such, actively contributes to developing the company as a focused, sustainable, global pharmaceutical company. The Board of Directors supervises Executive Management in its decisions and operations. The Board of Directors may also distribute extraordinary dividends, issue new shares or buy back shares in accordance with authorisations granted by the annual general meeting and recorded in the meeting minutes. For the minutes of annual general meetings, see novonordisk.com/about_us. The Board of Directors has 11 members, seven of whom are elected by shareholders and four by employees in Denmark. Novo Nordiskâs Board of Directors met eight times during 2016.</td></tr><tr><td colspan="1">Shareholder-elected board members serve a one-year term and may be re-elected. Members must retire at the first annual general meeting after reaching the age of 70. Two board members are members of the Board of Directors of Novo A/S and may be regarded as representing the interests of the controlling shareholder, while five of the seven shareholder-elected board members are independent as defined by the Danish Corporate Governance Recommendations. Read more on pp 54â55.</td></tr><tr><td colspan="1">A proposal for nomination of board members is presented by the Nomination Committee to the Board of Directors, taking into account required competences as defined by the Board of Directorsâ competence profile and reflecting the results of a self-assessment process facilitated by internal or external consultants. The assessment process is based on written questionnaires and evaluates the Board of Directorsâ composition and the skills of its members, including whether each board member and executive participates actively in board discussions and contributes with independent judgement.</td></tr><tr><td colspan="1">The self-assessment conducted in 2016 was facilitated internally and revealed good collaboration between the Board of Directors and Executive Management. The process also resulted in increased focus by the Board on the research strategy and sales in the US as well as on strengthening the processes in relation to board nomination and executive succession. In order to support continued fulfilment of the Novo Nordisk Way, criteria for board members include integrity, accountability, fairness, financial literacy, commitment and desire for innovation. Members are also expected to have experience of managing major companies that develop, manufacture and market products and services globally. The competence profile, which includes the nomination criteria, is available at novonordisk.com/about_us.</td></tr><tr><td colspan="1">To ensure that discussions include multiple perspectives representing the complex, global pharmaceutical environment, the Board of Directors aspires to be diverse in gender and nationality. Currently, three shareholder-elected board members are female and five of the seven shareholder-elected board members are non-Nordic. In 2016, the Board of Directors adjusted its diversity ambition and set out new targets with the aim that by 2020 it will consist of at least two shareholder-elected board members with Nordic nationality and at least two shareholder-elected board members with a nationality other than Nordic â and at least three shareholder-elected board members of each gender. In accordance with section 99b of the Danish Financial Statements Act, Novo Nordisk discloses its diversity policy, targets and current performance in the UN Global Compact Communication on Progress, which is available at novonordisk.com/annualreport.</td></tr><tr><td colspan="1">Under Danish law, Novo Nordiskâs employees in Denmark are entitled to be represented by half of the total number of board members elected at the annual general meeting. In 2014, employees elected four board members from among themselves â two male and two female, all Danes. Board members elected by employees serve a four-year term and have the same rights, duties and responsibilities as shareholder-elected board members.</td></tr><tr><td colspan="1">CHAIRMANSHIP</td></tr><tr><td colspan="1">The annual general meeting directly elects the chairman and the vice chairman of the Board of Directors. The Chairmanship carries out administrative tasks, such as planning board meetings to ensure a balance between overall strategy-setting and financial and managerial supervision of the company. Other tasks include reviewing the fixed asset investment portfolio. In March 2016, the Annual General Meeting re-elected the Chairman, Göran Ando, and the Vice Chairman, Jeppe Christiansen. In 2016, the Chairmanship particularly discussed the succession of the CEO and the reorganisation of the Executive Management as well as the companyâs research strategy and performance in the US. See novonordisk.com/about_us for a report on the Chairmanshipâs activities.</td></tr><tr><td colspan="1">AUDIT COMMITTEE</td></tr><tr><td colspan="1">The four members of the Audit Committee are elected by the Board of Directors from among its members. One member is an employee representative. Pursuant to the US Securities Exchange Act, two members qualify as independent while two members rely on an exemption from the independence requirements. In addition, two members have been designated as financial experts as defined by the US Securities and Exchange Commission (SEC). Under Danish law, two members qualify as independent â of whom one also qualifies as a financial expert. The Audit Committee assists the Board of Directors with oversight of the external auditors, the internal audit function, the procedure for handling complaints, financial, social and environmental reporting, business ethics compliance, significant investment projects (post-completion review), long-term incentive programmes, information security and other tasks. In 2016, the Board of Directors elected Liz Hewitt as Chairman and Jeppe Christiansen, Sylvie Grégoire and Stig Strøbæk as members. In 2016, the Audit Committee particularly discussed accounting policies and estimates, including tax, as well as internal controls and management of key risks, such as information security. See novonordisk.com/about_us for a report on the Audit Committeeâs activities.</td></tr><tr><td colspan="1">NOMINATION COMMITTEE</td></tr><tr><td colspan="1">The Nomination Committee consists of four members. Two members qualify as independent, while one member is an employee representative. The Nomination Committee assists the Board with oversight of the competence profile and composition of the Board, nomination of members and com- mittees, and other tasks on an ad hoc basis as specifically decided by the Board. In 2016, the Board of Directors elected Göran Ando as Chairman and Bruno Angelici, Liz Hewitt and Liselotte Hyveled as members. In 2016, the Nomination Committee particularly discussed long-term succession and profiles of potential candidates in addition to inter- viewing candidates. See novonordisk.com/about_us for a report on the Nomination Committeeâs activities.</td></tr><tr><td colspan="1">REMUNERATION COMMITTEE</td></tr><tr><td colspan="1">The Remuneration Committee consists of four members. One member qualifies as independent, while one member is an employee representative. The Remuneration Committee assists the Board with oversight of the remuneration policy as well as the actual remuneration of board members, board committees and Executive Management. In 2016, the Board of Directors elected Göran Ando as Chairman and Jeppe Christiansen, Søren Thuesen Pedersen and Mary Szela as members. In 2016, the Remuneration Committee particularly discussed remuneration levels for the executives following the reorganisation of Executive Management. See novonordisk.com/about_us for a report on the Remuneration Committeeâs activities.</td></tr><tr><td colspan="1">EXECUTIVE MANAGEMENT</td></tr><tr><td colspan="1">Executive Management is responsible for the day-to-day management of the company. In 2016, the Board of Directors decided to reorganise Executive Management, following which the president &amp; CEO, Lars Rebien Sørensen, retired from the company at the end of 2016 and was succeeded by Lars Fruergaard Jørgensen, previously executive vice president of Corporate Development. In addition, two executives left the company. The executives Jakob Riis and Maziar Mike Doustdar, who are based outside Denmark with responsibility for North America Operations and International Operations respectively, are not registered with the Danish Business Authority. Executive Management now consists of the president &amp; CEO plus five executives. They are responsible for the overall conduct of the business and all operational matters, the organisation of the company, allocation of resources, determination and implementation of strategies and policies, direction-setting, and ensuring timely reporting and provision of information to the Board of Directors and Novo Nordiskâs stakeholders. Executive Management meets at least once a month and often more frequently. The Board of Directors appoints members of Executive Management and determines their remuneration. The Chairmanship reviews the performance of the executives. To ensure the organisational implementation of the strategy, Executive Management has established a Senior Management Board consisting of the chief executive officer, executive vice presidents and senior vice presidents.</td></tr><tr><td colspan="1">ASSURANCE</td></tr><tr><td colspan="1">The companyâs financial reporting and the internal controls of financial reporting processes are audited by an independent audit firm elected at the annual general meeting. As part of Novo Nordiskâs com- mitment to its social and environmental responsibility, the company voluntarily includes an assurance report for social and environmental reporting in the annual report. The assurance provider reviews whether the social and environmental performance information covers aspects deemed to be material, and verifies the internal control processes for the information reported.</td></tr><tr><td colspan="1">Novo Nordiskâs internal audit function pro- vides independent and objective assurance, primarily within internal control of financial processes, IT and business ethics. To ensure that the internal financial audit function operates independently of Executive Management, its charter, audit plan and budget are approved by the Audit Committee. The Audit Committee must approve the appointment, remuneration and dismis- sal of the head of the internal audit function.</td></tr><tr><td colspan="1">Three other types of assurance activity â quality audits, organisational audits and values audits, called facilitations â help ensure that the company adheres to high quality standards and operates in accordance with the Novo Nordisk Way.</td></tr><tr><td colspan="1">COMPLIANCE WITH</td></tr><tr><td colspan="1">CORPORATE GOVERNANCE CODES</td></tr><tr><td colspan="1">Novo Nordiskâs B shares are listed on Nasdaq Copenhagen and on the New York Stock Exchange (NYSE) as American Depository Receipts (ADRs). The applicable corporate governance codes for each stock exchange and a review of Novo Nordiskâs compliance are available at novonordisk.com/about_us. In accordance with section 107b of the Danish Financial Statements Act, Novo Nordisk discloses its mandatory corporate governance report at novonordisk.com/about-novo-nordisk/corporate-governance/Recommendations-and-practices.html. Today, Novo Nordisk adheres to all but the following recommendations</td></tr><tr><td colspan="1">The responsibility for the remuneration policy applicable to the employees in general lies with Executive Management and not with the Remuneration Committee.</td></tr><tr><td colspan="1">Two executive employment contracts entered into before 2008 allow for severance payments of more than 24 monthsâ fixed base salary plus pension contribution.</td></tr><tr><td colspan="1">The majority of the members of the Audit Committee, the Nomination Committee and the Remuneration Committee respectively are not independent.</td></tr><tr><td colspan="1">Novo Nordisk complies with the corporate governance standards of NYSE applicable to foreign listed private issuers. As a controlled company, Novo Nordisk is not obliged to comply with all the standards established by NYSE. Furthermore, Novo Nordisk, as a foreign private issuer, is permitted to follow home country practice, which is the case in relation to independence requirements, audit committee, equity compensation plans, code of business conduct and ethics, and CEO certification. A summary of the significant ways in which Novo Nordiskâs corporate governance practices differ from the NYSE corporate governance listing standards can be found in the corporate governance report at novonordisk.com/about-novo-nordisk/corporate-governance/Recommendations-and-practices.html.</td></tr><tr><td colspan="1">Novo Nordisk is part of the Novo Group and adheres to the Charter for Companies in the Novo Group, which is available at novo.dk.</td></tr></table></mrv:CorporateGovernanceReport>
<mrv:StatementOfTargetFiguresAndPoliciesForTheUnderrepresentedGender contextRef="ctx1" xml:lang="en"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">To ensure that discussions include multiple perspectives representing the complex, global pharmaceutical environment, the Board of Directors aspires to be diverse in gender and nationality. Currently, three shareholder-elected board members are female and five of the seven shareholder-elected board members are non-Nordic. In 2016, the Board of Directors adjusted its diversity ambition and set out new targets with the aim that by 2020 it will consist of at least two shareholder-elected board members with Nordic nationality and at least two shareholder-elected board members with a nationality other than Nordic â and at least three shareholder-elected board members of each gender. In accordance with section 99b of the Danish Financial Statements Act, Novo Nordisk discloses its diversity policy, targets and current performance in the UN Global Compact Communication on Progress, which is available at novonordisk.com/annualreport</td></tr></table></mrv:StatementOfTargetFiguresAndPoliciesForTheUnderrepresentedGender>
<mrv:StatementOfCorporateSocialResponsibility contextRef="ctx1" xml:lang="en"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">General reporting standards and principles</td></tr><tr><td colspan="1">The Consolidated social statement has been prepared in accordance with</td></tr><tr><td colspan="1">the Danish Financial Statements Act (FSA), sections 99a and 99b.</td></tr><tr><td colspan="1">Section 99a requires Novo Nordisk to account for the companyâs activities</td></tr><tr><td colspan="1">relating to social responsibility, reporting on business model, signiï¬cant</td></tr><tr><td colspan="1">risks, business strategies, and activities in the areas of human rights, labour</td></tr><tr><td colspan="1">standards, environment, anti-corruption and climate. Section 99b requires</td></tr><tr><td colspan="1">Novo Nordisk to account for the gender diversity at Board level by</td></tr><tr><td colspan="1">reporting on targets and policies ensuring increased gender diversity over</td></tr><tr><td colspan="1">time. A detailed discussion of risks, policies and performance is available</td></tr><tr><td colspan="1">in Novo Nordiskâs annual Communication on Progress to the UN Global</td></tr><tr><td colspan="1">Compact at novonordisk.com/annualreport and on the UN Global</td></tr><tr><td colspan="1">Compactâs website at unglobalcompact.org/COP</td></tr></table></mrv:StatementOfCorporateSocialResponsibility>
<gsd:NameOfReportingEntity contextRef="ctx1" xml:lang="en">Novo Nordisk A/S</gsd:NameOfReportingEntity>
<gsd:AddressOfReportingEntityStreetName contextRef="ctx1" xml:lang="en">Novo Allé</gsd:AddressOfReportingEntityStreetName>
<gsd:AddressOfReportingEntityPostCodeIdentifier contextRef="ctx1" xml:lang="en">2880</gsd:AddressOfReportingEntityPostCodeIdentifier>
<gsd:AddressOfReportingEntityDistrictName contextRef="ctx1" xml:lang="en">Bagsværd</gsd:AddressOfReportingEntityDistrictName>
<gsd:AddressOfReportingEntityCountry contextRef="ctx1" xml:lang="en">Denmark</gsd:AddressOfReportingEntityCountry>
<gsd:IdentificationNumberCvrOfReportingEntity contextRef="ctx1">24256790</gsd:IdentificationNumberCvrOfReportingEntity>
<gsd:TelephoneNumberOfReportingEntity contextRef="ctx1" xml:lang="en">+45 4444 8888</gsd:TelephoneNumberOfReportingEntity>
<gsd:HomepageOfReportingEntity contextRef="ctx1">www.novonordisk.com</gsd:HomepageOfReportingEntity>
<gsd:NameAndSurnameOfChairmanOfGeneralMeeting contextRef="ctx1" xml:lang="en">Klaus Søgaard</gsd:NameAndSurnameOfChairmanOfGeneralMeeting>
<gsd:DateOfGeneralMeeting contextRef="ctx1">2017-03-23</gsd:DateOfGeneralMeeting>
<ifrs-dk:NetSales contextRef="ctx1" unitRef="vDKK" decimals="-6">111780000000</ifrs-dk:NetSales>
<ifrs-full:CostOfSales contextRef="ctx1" unitRef="vDKK" decimals="-6">17183000000</ifrs-full:CostOfSales>
<ifrs-full:GrossProfit contextRef="ctx1" unitRef="vDKK" decimals="-6">94597000000</ifrs-full:GrossProfit>
<ifrs-dk:SalesCostAndDistributionsCosts contextRef="ctx1" unitRef="vDKK" decimals="-6">28377000000</ifrs-dk:SalesCostAndDistributionsCosts>
<ifrs-full:ResearchAndDevelopmentExpense contextRef="ctx1" unitRef="vDKK" decimals="-6">14563000000</ifrs-full:ResearchAndDevelopmentExpense>
<ifrs-full:AdministrativeExpense contextRef="ctx1" unitRef="vDKK" decimals="-6">3962000000</ifrs-full:AdministrativeExpense>
<ifrs-full:OtherIncome contextRef="ctx1" unitRef="vDKK" decimals="-6">737000000</ifrs-full:OtherIncome>
<ifrs-full:ProfitLossFromOperatingActivities contextRef="ctx1" unitRef="vDKK" decimals="-6">48432000000</ifrs-full:ProfitLossFromOperatingActivities>
<ifrs-full:FinanceIncome contextRef="ctx1" unitRef="vDKK" decimals="-6">92000000</ifrs-full:FinanceIncome>
<ifrs-full:FinanceCosts contextRef="ctx1" unitRef="vDKK" decimals="-6">726000000</ifrs-full:FinanceCosts>
<ifrs-full:ProfitLossBeforeTax contextRef="ctx1" unitRef="vDKK" decimals="-6">47798000000</ifrs-full:ProfitLossBeforeTax>
<ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="ctx1" unitRef="vDKK" decimals="-6">9873000000</ifrs-full:IncomeTaxExpenseContinuingOperations>
<ifrs-full:ProfitLoss contextRef="ctx1" unitRef="vDKK" decimals="-6">37925000000</ifrs-full:ProfitLoss>
<ifrs-full:BasicEarningsLossPerShare contextRef="ctx1" unitRef="share" decimals="4">14.9900</ifrs-full:BasicEarningsLossPerShare>
<ifrs-full:DilutedEarningsLossPerShare contextRef="ctx1" unitRef="share" decimals="4">14.9600</ifrs-full:DilutedEarningsLossPerShare>
<ifrs-dk:OtherComprehensiveIncomeBeforeTaxActuarialGainsLossesOnDefinedBenefitPlans contextRef="ctx1" unitRef="vDKK" decimals="-6">-205000000</ifrs-dk:OtherComprehensiveIncomeBeforeTaxActuarialGainsLossesOnDefinedBenefitPlans>
<ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax contextRef="ctx1" unitRef="vDKK" decimals="-6">-7000000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax>
<ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax contextRef="ctx1" unitRef="vDKK" decimals="-6">-682000000</ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax>
<ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax contextRef="ctx1" unitRef="vDKK" decimals="-6">-1911000000</ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax>
<ifrs-dk:OtherComprehensiveIncomeOtherCost contextRef="ctx1" unitRef="vDKK" decimals="-6">74000000</ifrs-dk:OtherComprehensiveIncomeOtherCost>
<ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="ctx1" unitRef="vDKK" decimals="-6">-324000000</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
<ifrs-full:OtherComprehensiveIncome contextRef="ctx1" unitRef="vDKK" decimals="-6">-1191000000</ifrs-full:OtherComprehensiveIncome>
<ifrs-full:ComprehensiveIncome contextRef="ctx1" unitRef="vDKK" decimals="-6">36734000000</ifrs-full:ComprehensiveIncome>
<ifrs-full:AdjustmentsForIncomeTaxExpense contextRef="ctx1" unitRef="vDKK" decimals="-6">9873000000</ifrs-full:AdjustmentsForIncomeTaxExpense>
<ifrs-dk:AdjustmentsForDepreciationAndImpairmentLoss contextRef="ctx1" unitRef="vDKK" decimals="-6">3193000000</ifrs-dk:AdjustmentsForDepreciationAndImpairmentLoss>
<ifrs-full:OtherAdjustmentsForNoncashItems contextRef="ctx1" unitRef="vDKK" decimals="-6">3882000000</ifrs-full:OtherAdjustmentsForNoncashItems>
<ifrs-dk:AdjustmentsForDecreaseIncreaseInWorkingCapital contextRef="ctx1" unitRef="vDKK" decimals="-6">-3708000000</ifrs-dk:AdjustmentsForDecreaseIncreaseInWorkingCapital>
<ifrs-full:InterestReceivedClassifiedAsOperatingActivities contextRef="ctx1" unitRef="vDKK" decimals="-6">114000000</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
<ifrs-full:InterestPaidClassifiedAsOperatingActivities contextRef="ctx1" unitRef="vDKK" decimals="-6">66000000</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
<ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities contextRef="ctx1" unitRef="vDKK" decimals="-6">2899000000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
<ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="ctx1" unitRef="vDKK" decimals="-6">48314000000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
<ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities contextRef="ctx1" unitRef="vDKK" decimals="-6">0</ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
<ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="ctx1" unitRef="vDKK" decimals="-6">1199000000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
<ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="ctx1" unitRef="vDKK" decimals="-6">7000000</ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
<ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="ctx1" unitRef="vDKK" decimals="-6">7068000000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
<ifrs-dk:ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities contextRef="ctx1" unitRef="vDKK" decimals="-6">23000000</ifrs-dk:ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities>
<ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities contextRef="ctx1" unitRef="vDKK" decimals="-6">112000000</ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities>
<ifrs-full:DividendsReceivedClassifiedAsInvestingActivities contextRef="ctx1" unitRef="vDKK" decimals="-6">26000000</ifrs-full:DividendsReceivedClassifiedAsInvestingActivities>
<ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="ctx1" unitRef="vDKK" decimals="-6">-6790000000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
<ifrs-dk:PurchaseSaleOfTreasuryAssets contextRef="ctx1" unitRef="vDKK" decimals="-6">15057000000</ifrs-dk:PurchaseSaleOfTreasuryAssets>
<ifrs-full:DividendsPaidClassifiedAsFinancingActivities contextRef="ctx1" unitRef="vDKK" decimals="-6">23830000000</ifrs-full:DividendsPaidClassifiedAsFinancingActivities>
<ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="ctx1" unitRef="vDKK" decimals="-6">-38887000000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
<ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="ctx1" unitRef="vDKK" decimals="-6">2637000000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
<ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="ctx1" unitRef="vDKK" decimals="-6">-26000000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
<arr:IndependentAuditorsReportsAudit contextRef="ctx1" xml:lang="en"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">Independent auditorsâ report</td></tr></table></arr:IndependentAuditorsReportsAudit>
<arr:AddresseeOfAuditorsReportOnAuditedFinancialStatements contextRef="ctx1" xml:lang="en"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">To the shareholders of Novo Nordisk A/S</td></tr></table></arr:AddresseeOfAuditorsReportOnAuditedFinancialStatements>
<arr:OpinionOnAuditedFinancialStatements contextRef="ctx1" xml:lang="en"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">Our opinion</td></tr><tr><td colspan="1">In our opinion, the Consolidated financial statements give a true and fair view of the Groupâs financial position at 31 December 2016 and of the results of the Groupâs operations and cash flows for the financial year 1 January to 31 December 2016 in accordance with International Financial Reporting Standards as adopted by the EU and further requirements in the Danish Financial Statements Act.</td></tr><tr><td colspan="1">Moreover, in our opinion, the Financial statements of the Parent Company give a true and fair view of the Parent Companyâs financial position at 31 December 2016 and of the results of the Parent Companyâs operations for the financial year 1 January to 31 December 2016 in accordance with the Danish Financial Statements Act.</td></tr><tr><td colspan="1">What we have audited</td></tr><tr><td colspan="1">Novo Nordisk A/Sâ Consolidated financial statements and the Financial statements of the parent company for the financial year 1 January to 31 December 2016, pp 57-96 and pp 114-118, comprise income statement, balance sheet, statement of changes in equity, and notes to the financial statements including summary of significant accounting policies for the Group as well as for the Parent Company and statement of comprehensive income and statement of cash flow for the Group. Collectively referred to as the âfinancial statementsâ.</td></tr></table></arr:OpinionOnAuditedFinancialStatements>
<arr:DescriptionOfQualificationsOfAuditedFinancialStatements contextRef="ctx1" xml:lang="en"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">Basis for Opinion</td></tr><tr><td colspan="1">We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the financial statements section of our report. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.</td></tr><tr><td colspan="1">Independence</td></tr><tr><td colspan="1">We are independent of the Group in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the ethical requirements that are relevant to our audit of the financial statements in Denmark. We have also fulfilled our other ethical responsibilities in accordance with the IESBA Code.</td></tr></table></arr:DescriptionOfQualificationsOfAuditedFinancialStatements>
<arr:KeyAuditMattersAudit contextRef="ctx1" xml:lang="en"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="2">Key Audit Matters</td></tr><tr><td colspan="2">Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the financial statements for 2016. These matters were addressed in the context of our audit of the financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.</td></tr><tr><td>Key Audit Matter</td><td>How our audit addressed the Key Audit Matter</td></tr><tr><td colspan="2">Revenue recognition relating to rebates and discounts in the US business</td></tr><tr><td>The Group sells to various customers in the USA, which can fall under certain commercial and government mandated contracts and reimbursement arrangements, of which the most significant are Managed Care, Medicare, Medicaid and charge-backs to wholesalers.</td><td>We have tested relevant controls including applicable information systems and Managementâs review controls.</td></tr><tr><td>These arrangements result in deductions to gross sales in arriving at net sales and give rise to obligations for the Group to provide customers with rebates, discounts and allowances, which for unsettled amounts are recognised as an accrual.</td><td>We have obtained Managementâs calculations for accruals under applicable schemes and assessed the significance of assumptions applied by comparing them to the Groupâs stated commercial policies, the terms of the applicable contracts, third party data and historical levels of paid rebates and discounts in the US business.</td></tr><tr><td>We have focused on this area as rebates, discounts and allowances are complex and because establishing an appropriate accrual requires significant judgement and estimation by Management. This judgement is particularly complex in a US healthcare environment in which competitive pricing pressure and product discounting are growing trends.</td><td>We have compared the assumptions to contracted prices, historical rebates, discounts, allowances and to current payment trends. We have also considered the historical accuracy of the Groupâs estimates in previous years.</td></tr><tr><td colspan="2">Refer to Note 2.1</td></tr><tr><td /><td>We have formed an independent assessment of the most significant elements of the accrual at 31 December 2016 using third party data and compared this expectation to the actual accrual recognised by the Group.</td></tr><tr><td colspan="2">Litigations</td></tr><tr><td /><td>We have tested relevant controls regarding capture of data and completeness and how Management assesses the need for a provision.</td></tr><tr><td colspan="2">The pharmaceutical industry is heavily regulated, which increases inherent litigation risk, and litigation and contingent liabilities may arise from product-specific and general legal proceedings, from guarantees, marketing practices, unethical behaviour or government investigations connected with the Groupâs activities.</td></tr><tr><td /><td>We have discussed the status of significant known actual and potential litigation with in-house legal counsel. We have obtained and substantively tested evidence to support the decisions and rationale for provisions held or decisions not to recognise provisions, including correspondence with legal counsel and other counter-parties to litigation and considered Managementâs assessment of the probability of defending any litigation and the reliability of estimating any provisions.</td></tr><tr><td colspan="2">We have focused on this area as the amounts involved are potentially material and the valuation of the provision is based on application of material judgement and estimation, and is therefore associated with uncertainty. Accordingly, unexpected adverse outcomes could significantly impact the Groupâs reported profit and statement of financial position.</td></tr><tr><td>Refer to Note 3.6.</td><td>We have developed an independent expectation of the litigation provision based on product litigation history and other available evidence to assess the valuation and completeness of the provisions recognised by the Group. We have obtained confirmations from external legal counsel to confirm our understanding of settled and outstanding litigation and asserted claims. We have evaluated significant adjustments to legal provisions recorded during the year to determine if they were indicative of management bias.</td></tr><tr><td /><td>We have tested the completeness of the external legal counsels from whom we have asked for direct confirmation by testing legal expenses on a sample basis and comparing to internal documents.</td></tr><tr><td colspan="2">Uncertain tax positions</td></tr><tr><td>The Group operates in a complex multinational tax environment and there are open tax and transfer pricing cases with domestic and foreign tax authorities.</td><td>We have tested relevant controls regarding capture of data and completeness and how Management assesses the need for a provision.</td></tr><tr><td>We have focused on this area as the amounts involved are potentially material and the valuation of tax assets and liabilities is associated with uncertainty and judgement.</td><td>In understanding and evaluating Managementâs judgements, we have considered the status of recent and current tax authority audits and enquiries, the outcome of previous claims, judgemental positions taken in tax returns and current year estimates, and developments in the tax environment.</td></tr><tr><td colspan="2">Refer to Note 2.6.</td></tr><tr><td /><td>In addition, we have used our own local and international tax specialists, evaluated the adequacy of Managementâs key assumptions and read correspondence with tax authorities to assess the valuation of tax assets and liabilities.</td></tr></table></arr:KeyAuditMattersAudit>
<arr:StatementOnManagementsReviewAuditorsReportOnAuditedFinancialStatements contextRef="ctx1" xml:lang="en"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">Statement on Managementâs Review</td></tr><tr><td colspan="1">Management is responsible for Managementâs Review (pp 1 â 56 and p 97).</td></tr><tr><td colspan="1">Our opinion on the financial statements does not cover Managementâs Review, and we do not express any form of assurance conclusion thereon.</td></tr><tr><td colspan="1">In connection with our audit of the financial statements, our responsibility is to read Managementâs Review and, in doing so, consider whether Managementâs Review is materially inconsistent with the financial statements or our knowledge obtained in the audit, or otherwise appears to be materially misstated.</td></tr><tr><td colspan="1">Moreover, we considered whether Managementâs Review includes the disclosures required by the Danish Financial Statements Act.</td></tr><tr><td colspan="1">Based on the work we have performed, in our view, Managementâs Review is in accordance with the Consolidated financial statements and the Financial statements of the Parent Company and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement in Managementâs Review.</td></tr></table></arr:StatementOnManagementsReviewAuditorsReportOnAuditedFinancialStatements>
<arr:StatementOfExecutiveAndSupervisoryBoardsResponsibilityForFinancialStatements contextRef="ctx1" xml:lang="en"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">Managementâs Responsibility for the Financial Statements</td></tr><tr><td colspan="1">Management is responsible for the preparation of Consolidated financial statements that give a true and fair view in accordance with International Financial Reporting Standards as adopted by the EU and further requirements in the Danish Financial Statements Act and for the preparation of Financial statements of the Parent Company that give a true and fair view in accordance with the Danish Financial Statements Act, and for such internal control as Management determines is necessary to enable the preparation of financial statements that are free from material misstatements, whether due to fraud or error.</td></tr><tr><td colspan="1">In preparing the financial statements, Management is responsible for assessing the Groupâs and Parent Companyâs ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless Management either intends to liquidate the Group or Parent Company or to cease operations, or has no realistic alternative but to do so.</td></tr></table></arr:StatementOfExecutiveAndSupervisoryBoardsResponsibilityForFinancialStatements>
<arr:StatementOfAuditorsResponsibilityForAuditAndAuditPerformed contextRef="ctx1" xml:lang="en"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">Auditorâs Responsibilities for the Audit of the Financial Statements</td></tr><tr><td colspan="1">Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditorâs report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs and the additional requirements applicable in Denmark will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.</td></tr><tr><td colspan="1">As part of an audit in accordance with ISAs and the additional requirements applicable in Denmark, we exercise professional judgement and maintain professional scepticism throughout the audit. We also</td></tr><tr><td colspan="1">·       Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations or the override of internal control.</td></tr><tr><td colspan="1">·       Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Groupâs and the Parent Companyâs internal control.</td></tr><tr><td colspan="1">·       Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by Management.</td></tr><tr><td colspan="1">·       Conclude on the appropriateness of Managementâs use of the going concern basis of accounting and based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Groupâs and the Parent Companyâs ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditorâs report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our Auditorâs Report. However, future events or conditions may cause the Group or the Parent Company to cease to continue as a going concern.</td></tr><tr><td colspan="1">·       Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that achieves fair presentation.</td></tr><tr><td colspan="1">·       Obtain sufficient appropriate audit evidence regarding the financial information of the entities or business activities within the Group to express an opinion on the Consolidated financial statements. We are responsible for the direction, supervision and performance of the group audit. We remain solely responsible for our audit opinion.</td></tr><tr><td colspan="1">We communicate with those charged with governance (the Board of Directors) regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.</td></tr><tr><td colspan="1">We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.</td></tr><tr><td colspan="1">From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the financial statements of the current period and are therefore the key audit matters. We describe these matters in our Auditorâs Report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication.</td></tr></table></arr:StatementOfAuditorsResponsibilityForAuditAndAuditPerformed>
<arr:SignatureOfAuditorsPlace contextRef="ctx1" xml:lang="en">Bagsværd</arr:SignatureOfAuditorsPlace>
<arr:SignatureOfAuditorsDate contextRef="ctx1">2017-02-01</arr:SignatureOfAuditorsDate>
<sob:StatementByExecutiveAndSupervisoryBoards contextRef="ctx1" xml:lang="en"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">Statement by the Board of Directors and Executive Management on the Annual Report</td></tr></table></sob:StatementByExecutiveAndSupervisoryBoards>
<sob:IdentificationOfApprovedAnnualReport contextRef="ctx1" xml:lang="en"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">Today, the Board of Directors and Executive Management approved the Annual Report of Novo Nordisk A/S for the year 2016. The Board of Directors and Executive Management are jointly responsible for ensuring the integrity and quality of the report.</td></tr></table></sob:IdentificationOfApprovedAnnualReport>
<sob:ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement contextRef="ctx1" xml:lang="en"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">The Annual Report has been prepared in accordance with the International Integrated Reporting Framework.</td></tr><tr><td colspan="1">The Consolidated financial statements have been prepared in accordance with International Financial Reporting Standards as adopted by the EU and further requirements in the Danish Financial Statements Act.</td></tr><tr><td colspan="1">Further, the Financial statements of the parent company and Managementâs Review have been prepared in accordance with the Danish Financial Statements Act.</td></tr></table></sob:ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement>
<sob:ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults contextRef="ctx1" xml:lang="en"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">In our opinion, the Consolidated financial statements and the Financial statements of the parent company give a true and fair view of the financial position at 31 December 2016, the results of the Groupâs and parent companyâs operations, and consolidated cash flows for the financial year 2016.</td></tr></table></sob:ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults>
<sob:ManagementsStatementAboutManagementsReview contextRef="ctx1" xml:lang="en"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">Furthermore, in our opinion, Management's Review includes a true and fair account of the development in the operations and financial circumstances, of the results for the year, and of the financial position of the Group and the parent company as well as a description of the most significant risks and elements of uncertainty facing the Group and the parent company.</td></tr></table></sob:ManagementsStatementAboutManagementsReview>
<sob:ConfirmationThatSupplementaryReportsGiveTrueAndFairViewInAccordanceWithGenerallyAcceptedGuidelinesForSuchReports contextRef="ctx1" xml:lang="en"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">Novo Nordiskâs Consolidated social and environmental statements have been prepared in accordance with the reporting principles of materiality, inclusivity and responsiveness of AA1000APS(2008) and social and environmental accounting policies. They give a true and fair account and a balanced and reasonable presentation of the organisationâs social and environmental performance in accordance with these principles.</td></tr></table></sob:ConfirmationThatSupplementaryReportsGiveTrueAndFairViewInAccordanceWithGenerallyAcceptedGuidelinesForSuchReports>
<sob:RecommendationForApprovalOfAnnualReportByGeneralMeeting contextRef="ctx1" xml:lang="en"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">We recommend that the Annual Report be adopted at the Annual General Meeting.</td></tr></table></sob:RecommendationForApprovalOfAnnualReportByGeneralMeeting>
<sob:PlaceOfSignatureOfStatement contextRef="ctx1" xml:lang="en">Bagsværd</sob:PlaceOfSignatureOfStatement>
<sob:DateOfApprovalOfAnnualReport contextRef="ctx1">2017-02-01</sob:DateOfApprovalOfAnnualReport>
<gsd:InformationOnTypeOfSubmittedReport contextRef="ctx1">Ã
rsrapport</gsd:InformationOnTypeOfSubmittedReport>
<gsd:IdentificationNumberCvrOfSubmittingEnterprise contextRef="ctx1">24256790</gsd:IdentificationNumberCvrOfSubmittingEnterprise>
<gsd:NameOfSubmittingEnterprise contextRef="ctx1" xml:lang="en">Novo Nordisk A/S</gsd:NameOfSubmittingEnterprise>
<gsd:AddressOfSubmittingEnterpriseStreetAndNumber contextRef="ctx1" xml:lang="en">Novo Allé 1</gsd:AddressOfSubmittingEnterpriseStreetAndNumber>
<gsd:AddressOfSubmittingEnterprisePostcodeAndTown contextRef="ctx1" xml:lang="en">2880 Bagsværd</gsd:AddressOfSubmittingEnterprisePostcodeAndTown>
<gsd:PrecedingReportingPeriodStartDate contextRef="ctx1">2015-01-01</gsd:PrecedingReportingPeriodStartDate>
<gsd:PredingReportingPeriodEndDate contextRef="ctx1">2015-12-31</gsd:PredingReportingPeriodEndDate>
<cmn:TypeOfAuditorAssistance contextRef="ctx1">Revisionspåtegning</cmn:TypeOfAuditorAssistance>
<ifrs-dk:NetSales contextRef="ctx2" unitRef="vDKK" decimals="-6">107927000000</ifrs-dk:NetSales>
<ifrs-full:CostOfSales contextRef="ctx2" unitRef="vDKK" decimals="-6">16188000000</ifrs-full:CostOfSales>
<ifrs-full:GrossProfit contextRef="ctx2" unitRef="vDKK" decimals="-6">91739000000</ifrs-full:GrossProfit>
<ifrs-dk:SalesCostAndDistributionsCosts contextRef="ctx2" unitRef="vDKK" decimals="-6">28312000000</ifrs-dk:SalesCostAndDistributionsCosts>
<ifrs-full:ResearchAndDevelopmentExpense contextRef="ctx2" unitRef="vDKK" decimals="-6">13608000000</ifrs-full:ResearchAndDevelopmentExpense>
<ifrs-full:AdministrativeExpense contextRef="ctx2" unitRef="vDKK" decimals="-6">3857000000</ifrs-full:AdministrativeExpense>
<ifrs-full:OtherIncome contextRef="ctx2" unitRef="vDKK" decimals="-6">3482000000</ifrs-full:OtherIncome>
<ifrs-full:ProfitLossFromOperatingActivities contextRef="ctx2" unitRef="vDKK" decimals="-6">49444000000</ifrs-full:ProfitLossFromOperatingActivities>
<ifrs-full:FinanceIncome contextRef="ctx2" unitRef="vDKK" decimals="-6">85000000</ifrs-full:FinanceIncome>
<ifrs-full:FinanceCosts contextRef="ctx2" unitRef="vDKK" decimals="-6">6046000000</ifrs-full:FinanceCosts>
<ifrs-full:ProfitLossBeforeTax contextRef="ctx2" unitRef="vDKK" decimals="-6">43483000000</ifrs-full:ProfitLossBeforeTax>
<ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="ctx2" unitRef="vDKK" decimals="-6">8623000000</ifrs-full:IncomeTaxExpenseContinuingOperations>
<ifrs-full:ProfitLoss contextRef="ctx2" unitRef="vDKK" decimals="-6">34860000000</ifrs-full:ProfitLoss>
<ifrs-full:BasicEarningsLossPerShare contextRef="ctx2" unitRef="share" decimals="4">13.5600</ifrs-full:BasicEarningsLossPerShare>
<ifrs-full:DilutedEarningsLossPerShare contextRef="ctx2" unitRef="share" decimals="4">13.5200</ifrs-full:DilutedEarningsLossPerShare>
<ifrs-dk:OtherComprehensiveIncomeBeforeTaxActuarialGainsLossesOnDefinedBenefitPlans contextRef="ctx2" unitRef="vDKK" decimals="-6">-37000000</ifrs-dk:OtherComprehensiveIncomeBeforeTaxActuarialGainsLossesOnDefinedBenefitPlans>
<ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax contextRef="ctx2" unitRef="vDKK" decimals="-6">-669000000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax>
<ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax contextRef="ctx2" unitRef="vDKK" decimals="-6">-2216000000</ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax>
<ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax contextRef="ctx2" unitRef="vDKK" decimals="-6">-681000000</ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax>
<ifrs-dk:OtherComprehensiveIncomeOtherCost contextRef="ctx2" unitRef="vDKK" decimals="-6">-366000000</ifrs-dk:OtherComprehensiveIncomeOtherCost>
<ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="ctx2" unitRef="vDKK" decimals="-6">87000000</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
<ifrs-full:OtherComprehensiveIncome contextRef="ctx2" unitRef="vDKK" decimals="-6">1108000000</ifrs-full:OtherComprehensiveIncome>
<ifrs-full:ComprehensiveIncome contextRef="ctx2" unitRef="vDKK" decimals="-6">35968000000</ifrs-full:ComprehensiveIncome>
<ifrs-full:AdjustmentsForIncomeTaxExpense contextRef="ctx2" unitRef="vDKK" decimals="-6">8623000000</ifrs-full:AdjustmentsForIncomeTaxExpense>
<ifrs-dk:AdjustmentsForDepreciationAndImpairmentLoss contextRef="ctx2" unitRef="vDKK" decimals="-6">2959000000</ifrs-dk:AdjustmentsForDepreciationAndImpairmentLoss>
<ifrs-full:OtherAdjustmentsForNoncashItems contextRef="ctx2" unitRef="vDKK" decimals="-6">5908000000</ifrs-full:OtherAdjustmentsForNoncashItems>
<ifrs-dk:AdjustmentsForDecreaseIncreaseInWorkingCapital contextRef="ctx2" unitRef="vDKK" decimals="-6">-2157000000</ifrs-dk:AdjustmentsForDecreaseIncreaseInWorkingCapital>
<ifrs-full:InterestReceivedClassifiedAsOperatingActivities contextRef="ctx2" unitRef="vDKK" decimals="-6">55000000</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
<ifrs-full:InterestPaidClassifiedAsOperatingActivities contextRef="ctx2" unitRef="vDKK" decimals="-6">61000000</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
<ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities contextRef="ctx2" unitRef="vDKK" decimals="-6">9374000000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
<ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="ctx2" unitRef="vDKK" decimals="-6">38287000000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
<ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities contextRef="ctx2" unitRef="vDKK" decimals="-6">2303000000</ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
<ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="ctx2" unitRef="vDKK" decimals="-6">1182000000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
<ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="ctx2" unitRef="vDKK" decimals="-6">15000000</ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
<ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="ctx2" unitRef="vDKK" decimals="-6">5224000000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
<ifrs-dk:ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities contextRef="ctx2" unitRef="vDKK" decimals="-6">32000000</ifrs-dk:ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities>
<ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities contextRef="ctx2" unitRef="vDKK" decimals="-6">9000000</ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities>
<ifrs-full:DividendsReceivedClassifiedAsInvestingActivities contextRef="ctx2" unitRef="vDKK" decimals="-6">0</ifrs-full:DividendsReceivedClassifiedAsInvestingActivities>
<ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="ctx2" unitRef="vDKK" decimals="-6">-6098000000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
<ifrs-dk:PurchaseSaleOfTreasuryAssets contextRef="ctx2" unitRef="vDKK" decimals="-6">17196000000</ifrs-dk:PurchaseSaleOfTreasuryAssets>
<ifrs-full:DividendsPaidClassifiedAsFinancingActivities contextRef="ctx2" unitRef="vDKK" decimals="-6">12905000000</ifrs-full:DividendsPaidClassifiedAsFinancingActivities>
<ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="ctx2" unitRef="vDKK" decimals="-6">-30101000000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
<ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="ctx2" unitRef="vDKK" decimals="-6">2088000000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
<ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="ctx2" unitRef="vDKK" decimals="-6">86000000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
<ifrs-dk:NetSales contextRef="ctx3" unitRef="vDKK" decimals="-6">88806000000</ifrs-dk:NetSales>
<ifrs-full:CostOfSales contextRef="ctx3" unitRef="vDKK" decimals="-6">14562000000</ifrs-full:CostOfSales>
<ifrs-full:GrossProfit contextRef="ctx3" unitRef="vDKK" decimals="-6">74244000000</ifrs-full:GrossProfit>
<ifrs-dk:SalesCostAndDistributionsCosts contextRef="ctx3" unitRef="vDKK" decimals="-6">23223000000</ifrs-dk:SalesCostAndDistributionsCosts>
<ifrs-full:ResearchAndDevelopmentExpense contextRef="ctx3" unitRef="vDKK" decimals="-6">13762000000</ifrs-full:ResearchAndDevelopmentExpense>
<ifrs-full:AdministrativeExpense contextRef="ctx3" unitRef="vDKK" decimals="-6">3537000000</ifrs-full:AdministrativeExpense>
<ifrs-full:OtherIncome contextRef="ctx3" unitRef="vDKK" decimals="-6">770000000</ifrs-full:OtherIncome>
<ifrs-full:ProfitLossFromOperatingActivities contextRef="ctx3" unitRef="vDKK" decimals="-6">34492000000</ifrs-full:ProfitLossFromOperatingActivities>
<ifrs-full:FinanceIncome contextRef="ctx3" unitRef="vDKK" decimals="-6">167000000</ifrs-full:FinanceIncome>
<ifrs-full:FinanceCosts contextRef="ctx3" unitRef="vDKK" decimals="-6">563000000</ifrs-full:FinanceCosts>
<ifrs-full:ProfitLossBeforeTax contextRef="ctx3" unitRef="vDKK" decimals="-6">34096000000</ifrs-full:ProfitLossBeforeTax>
<ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="ctx3" unitRef="vDKK" decimals="-6">7615000000</ifrs-full:IncomeTaxExpenseContinuingOperations>
<ifrs-full:ProfitLoss contextRef="ctx3" unitRef="vDKK" decimals="-6">26481000000</ifrs-full:ProfitLoss>
<ifrs-full:BasicEarningsLossPerShare contextRef="ctx3" unitRef="share" decimals="4">10.1000</ifrs-full:BasicEarningsLossPerShare>
<ifrs-full:DilutedEarningsLossPerShare contextRef="ctx3" unitRef="share" decimals="4">10.0700</ifrs-full:DilutedEarningsLossPerShare>
<ifrs-dk:OtherComprehensiveIncomeBeforeTaxActuarialGainsLossesOnDefinedBenefitPlans contextRef="ctx3" unitRef="vDKK" decimals="-6">-247000000</ifrs-dk:OtherComprehensiveIncomeBeforeTaxActuarialGainsLossesOnDefinedBenefitPlans>
<ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax contextRef="ctx3" unitRef="vDKK" decimals="-6">-39000000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax>
<ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax contextRef="ctx3" unitRef="vDKK" decimals="-6">1229000000</ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax>
<ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax contextRef="ctx3" unitRef="vDKK" decimals="-6">-2225000000</ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax>
<ifrs-dk:OtherComprehensiveIncomeOtherCost contextRef="ctx3" unitRef="vDKK" decimals="-6">-111000000</ifrs-dk:OtherComprehensiveIncomeOtherCost>
<ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="ctx3" unitRef="vDKK" decimals="-6">-977000000</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
<ifrs-full:OtherComprehensiveIncome contextRef="ctx3" unitRef="vDKK" decimals="-6">-2652000000</ifrs-full:OtherComprehensiveIncome>
<ifrs-full:ComprehensiveIncome contextRef="ctx3" unitRef="vDKK" decimals="-6">23829000000</ifrs-full:ComprehensiveIncome>
<ifrs-full:AdjustmentsForIncomeTaxExpense contextRef="ctx3" unitRef="vDKK" decimals="-6">7615000000</ifrs-full:AdjustmentsForIncomeTaxExpense>
<ifrs-dk:AdjustmentsForDepreciationAndImpairmentLoss contextRef="ctx3" unitRef="vDKK" decimals="-6">3435000000</ifrs-dk:AdjustmentsForDepreciationAndImpairmentLoss>
<ifrs-full:OtherAdjustmentsForNoncashItems contextRef="ctx3" unitRef="vDKK" decimals="-6">4163000000</ifrs-full:OtherAdjustmentsForNoncashItems>
<ifrs-dk:AdjustmentsForDecreaseIncreaseInWorkingCapital contextRef="ctx3" unitRef="vDKK" decimals="-6">-2148000000</ifrs-dk:AdjustmentsForDecreaseIncreaseInWorkingCapital>
<ifrs-full:InterestReceivedClassifiedAsOperatingActivities contextRef="ctx3" unitRef="vDKK" decimals="-6">131000000</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
<ifrs-full:InterestPaidClassifiedAsOperatingActivities contextRef="ctx3" unitRef="vDKK" decimals="-6">78000000</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
<ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities contextRef="ctx3" unitRef="vDKK" decimals="-6">7907000000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
<ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="ctx3" unitRef="vDKK" decimals="-6">31692000000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
<ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities contextRef="ctx3" unitRef="vDKK" decimals="-6">0</ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
<ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="ctx3" unitRef="vDKK" decimals="-6">321000000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
<ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="ctx3" unitRef="vDKK" decimals="-6">4000000</ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
<ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="ctx3" unitRef="vDKK" decimals="-6">3990000000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
<ifrs-dk:ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities contextRef="ctx3" unitRef="vDKK" decimals="-6">35000000</ifrs-dk:ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities>
<ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities contextRef="ctx3" unitRef="vDKK" decimals="-6">24000000</ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities>
<ifrs-full:DividendsReceivedClassifiedAsInvestingActivities contextRef="ctx3" unitRef="vDKK" decimals="-6">0</ifrs-full:DividendsReceivedClassifiedAsInvestingActivities>
<ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="ctx3" unitRef="vDKK" decimals="-6">-2064000000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
<ifrs-dk:PurchaseSaleOfTreasuryAssets contextRef="ctx3" unitRef="vDKK" decimals="-6">14667000000</ifrs-dk:PurchaseSaleOfTreasuryAssets>
<ifrs-full:DividendsPaidClassifiedAsFinancingActivities contextRef="ctx3" unitRef="vDKK" decimals="-6">11866000000</ifrs-full:DividendsPaidClassifiedAsFinancingActivities>
<ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="ctx3" unitRef="vDKK" decimals="-6">-26533000000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
<ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="ctx3" unitRef="vDKK" decimals="-6">3095000000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
<ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="ctx3" unitRef="vDKK" decimals="-6">68000000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
<ifrs-full:IntangibleAssetsAndGoodwill contextRef="ctx4" unitRef="vDKK" decimals="-6">2714000000</ifrs-full:IntangibleAssetsAndGoodwill>
<ifrs-full:PropertyPlantAndEquipment contextRef="ctx4" unitRef="vDKK" decimals="-6">30179000000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:InvestmentsInAssociates contextRef="ctx4" unitRef="vDKK" decimals="-6">809000000</ifrs-full:InvestmentsInAssociates>
<ifrs-full:DeferredTaxAssets contextRef="ctx4" unitRef="vDKK" decimals="-6">2683000000</ifrs-full:DeferredTaxAssets>
<ifrs-full:OtherNoncurrentFinancialAssets contextRef="ctx4" unitRef="vDKK" decimals="-6">1388000000</ifrs-full:OtherNoncurrentFinancialAssets>
<ifrs-full:NoncurrentAssets contextRef="ctx4" unitRef="vDKK" decimals="-6">37773000000</ifrs-full:NoncurrentAssets>
<ifrs-full:Inventories contextRef="ctx4" unitRef="vDKK" decimals="-6">14341000000</ifrs-full:Inventories>
<ifrs-full:CurrentTradeReceivables contextRef="ctx4" unitRef="vDKK" decimals="-6">20234000000</ifrs-full:CurrentTradeReceivables>
<ifrs-full:CurrentTaxAssetsCurrent contextRef="ctx4" unitRef="vDKK" decimals="-6">1552000000</ifrs-full:CurrentTaxAssetsCurrent>
<ifrs-full:OtherCurrentReceivables contextRef="ctx4" unitRef="vDKK" decimals="-6">2411000000</ifrs-full:OtherCurrentReceivables>
<ifrs-dk:CurrentSecurities contextRef="ctx4" unitRef="vDKK" decimals="-6">2009000000</ifrs-dk:CurrentSecurities>
<ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValue contextRef="ctx4" unitRef="vDKK" decimals="-6">529000000</ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValue>
<ifrs-full:Cash contextRef="ctx4" unitRef="vDKK" decimals="-6">18690000000</ifrs-full:Cash>
<ifrs-full:CurrentAssets contextRef="ctx4" unitRef="vDKK" decimals="-6">59766000000</ifrs-full:CurrentAssets>
<ifrs-full:Assets contextRef="ctx4" unitRef="vDKK" decimals="-6">97539000000</ifrs-full:Assets>
<ifrs-full:IssuedCapital contextRef="ctx4" unitRef="vDKK" decimals="-6">510000000</ifrs-full:IssuedCapital>
<ifrs-dk:ReserveForTreasuryShares contextRef="ctx4" unitRef="vDKK" decimals="-6">9000000</ifrs-dk:ReserveForTreasuryShares>
<ifrs-full:RetainedEarnings contextRef="ctx4" unitRef="vDKK" decimals="-6">46111000000</ifrs-full:RetainedEarnings>
<ifrs-full:OtherReserves contextRef="ctx4" unitRef="vDKK" decimals="-6">-1343000000</ifrs-full:OtherReserves>
<ifrs-full:Equity contextRef="ctx4" unitRef="vDKK" decimals="-6">45269000000</ifrs-full:Equity>
<ifrs-full:DeferredTaxLiabilities contextRef="ctx4" unitRef="vDKK" decimals="-6">13000000</ifrs-full:DeferredTaxLiabilities>
<ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan contextRef="ctx4" unitRef="vDKK" decimals="-6">1451000000</ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan>
<ifrs-full:NoncurrentProvisions contextRef="ctx4" unitRef="vDKK" decimals="-6">3370000000</ifrs-full:NoncurrentProvisions>
<ifrs-full:NoncurrentLiabilities contextRef="ctx4" unitRef="vDKK" decimals="-6">4834000000</ifrs-full:NoncurrentLiabilities>
<ifrs-full:OtherCurrentPayables contextRef="ctx4" unitRef="vDKK" decimals="-6">229000000</ifrs-full:OtherCurrentPayables>
<ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers contextRef="ctx4" unitRef="vDKK" decimals="-6">6011000000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
<ifrs-full:CurrentTaxLiabilitiesCurrent contextRef="ctx4" unitRef="vDKK" decimals="-6">3976000000</ifrs-full:CurrentTaxLiabilitiesCurrent>
<ifrs-full:OtherCurrentLiabilities contextRef="ctx4" unitRef="vDKK" decimals="-6">14181000000</ifrs-full:OtherCurrentLiabilities>
<ifrs-full:CurrentDerivativeFinancialLiabilities contextRef="ctx4" unitRef="vDKK" decimals="-6">2578000000</ifrs-full:CurrentDerivativeFinancialLiabilities>
<ifrs-full:CurrentProvisions contextRef="ctx4" unitRef="vDKK" decimals="-6">20461000000</ifrs-full:CurrentProvisions>
<ifrs-full:CurrentLiabilities contextRef="ctx4" unitRef="vDKK" decimals="-6">47436000000</ifrs-full:CurrentLiabilities>
<ifrs-full:Liabilities contextRef="ctx4" unitRef="vDKK" decimals="-6">52270000000</ifrs-full:Liabilities>
<ifrs-full:EquityAndLiabilities contextRef="ctx4" unitRef="vDKK" decimals="-6">97539000000</ifrs-full:EquityAndLiabilities>
<ifrs-full:CashAndCashEquivalents contextRef="ctx4" unitRef="vDKK" decimals="-6">18461000000</ifrs-full:CashAndCashEquivalents>
<ifrs-full:IntangibleAssetsAndGoodwill contextRef="ctx5" unitRef="vDKK" decimals="-6">2158000000</ifrs-full:IntangibleAssetsAndGoodwill>
<ifrs-full:PropertyPlantAndEquipment contextRef="ctx5" unitRef="vDKK" decimals="-6">25545000000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:InvestmentsInAssociates contextRef="ctx5" unitRef="vDKK" decimals="-6">811000000</ifrs-full:InvestmentsInAssociates>
<ifrs-full:DeferredTaxAssets contextRef="ctx5" unitRef="vDKK" decimals="-6">6806000000</ifrs-full:DeferredTaxAssets>
<ifrs-full:OtherNoncurrentFinancialAssets contextRef="ctx5" unitRef="vDKK" decimals="-6">1339000000</ifrs-full:OtherNoncurrentFinancialAssets>
<ifrs-full:NoncurrentAssets contextRef="ctx5" unitRef="vDKK" decimals="-6">36659000000</ifrs-full:NoncurrentAssets>
<ifrs-full:Inventories contextRef="ctx5" unitRef="vDKK" decimals="-6">12758000000</ifrs-full:Inventories>
<ifrs-full:CurrentTradeReceivables contextRef="ctx5" unitRef="vDKK" decimals="-6">15485000000</ifrs-full:CurrentTradeReceivables>
<ifrs-full:CurrentTaxAssetsCurrent contextRef="ctx5" unitRef="vDKK" decimals="-6">3871000000</ifrs-full:CurrentTaxAssetsCurrent>
<ifrs-full:OtherCurrentReceivables contextRef="ctx5" unitRef="vDKK" decimals="-6">2257000000</ifrs-full:OtherCurrentReceivables>
<ifrs-dk:CurrentSecurities contextRef="ctx5" unitRef="vDKK" decimals="-6">3542000000</ifrs-dk:CurrentSecurities>
<ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValue contextRef="ctx5" unitRef="vDKK" decimals="-6">304000000</ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValue>
<ifrs-full:Cash contextRef="ctx5" unitRef="vDKK" decimals="-6">16923000000</ifrs-full:Cash>
<ifrs-full:CurrentAssets contextRef="ctx5" unitRef="vDKK" decimals="-6">55140000000</ifrs-full:CurrentAssets>
<ifrs-full:Assets contextRef="ctx5" unitRef="vDKK" decimals="-6">91799000000</ifrs-full:Assets>
<ifrs-full:IssuedCapital contextRef="ctx5" unitRef="vDKK" decimals="-6">520000000</ifrs-full:IssuedCapital>
<ifrs-dk:ReserveForTreasuryShares contextRef="ctx5" unitRef="vDKK" decimals="-6">10000000</ifrs-dk:ReserveForTreasuryShares>
<ifrs-full:RetainedEarnings contextRef="ctx5" unitRef="vDKK" decimals="-6">46816000000</ifrs-full:RetainedEarnings>
<ifrs-full:OtherReserves contextRef="ctx5" unitRef="vDKK" decimals="-6">-357000000</ifrs-full:OtherReserves>
<ifrs-full:Equity contextRef="ctx5" unitRef="vDKK" decimals="-6">46969000000</ifrs-full:Equity>
<ifrs-full:DeferredTaxLiabilities contextRef="ctx5" unitRef="vDKK" decimals="-6">6000000</ifrs-full:DeferredTaxLiabilities>
<ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan contextRef="ctx5" unitRef="vDKK" decimals="-6">1186000000</ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan>
<ifrs-full:NoncurrentProvisions contextRef="ctx5" unitRef="vDKK" decimals="-6">2765000000</ifrs-full:NoncurrentProvisions>
<ifrs-full:NoncurrentLiabilities contextRef="ctx5" unitRef="vDKK" decimals="-6">3957000000</ifrs-full:NoncurrentLiabilities>
<ifrs-full:OtherCurrentPayables contextRef="ctx5" unitRef="vDKK" decimals="-6">1073000000</ifrs-full:OtherCurrentPayables>
<ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers contextRef="ctx5" unitRef="vDKK" decimals="-6">4927000000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
<ifrs-full:CurrentTaxLiabilitiesCurrent contextRef="ctx5" unitRef="vDKK" decimals="-6">3777000000</ifrs-full:CurrentTaxLiabilitiesCurrent>
<ifrs-full:OtherCurrentLiabilities contextRef="ctx5" unitRef="vDKK" decimals="-6">12655000000</ifrs-full:OtherCurrentLiabilities>
<ifrs-full:CurrentDerivativeFinancialLiabilities contextRef="ctx5" unitRef="vDKK" decimals="-6">1382000000</ifrs-full:CurrentDerivativeFinancialLiabilities>
<ifrs-full:CurrentProvisions contextRef="ctx5" unitRef="vDKK" decimals="-6">17059000000</ifrs-full:CurrentProvisions>
<ifrs-full:CurrentLiabilities contextRef="ctx5" unitRef="vDKK" decimals="-6">40873000000</ifrs-full:CurrentLiabilities>
<ifrs-full:Liabilities contextRef="ctx5" unitRef="vDKK" decimals="-6">44830000000</ifrs-full:Liabilities>
<ifrs-full:EquityAndLiabilities contextRef="ctx5" unitRef="vDKK" decimals="-6">91799000000</ifrs-full:EquityAndLiabilities>
<ifrs-full:CashAndCashEquivalents contextRef="ctx5" unitRef="vDKK" decimals="-6">15850000000</ifrs-full:CashAndCashEquivalents>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx6" xml:lang="en">Net profit</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx6" unitRef="vDKK" decimals="-6">37925000000</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx7" xml:lang="en">Net profit</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx7" unitRef="vDKK" decimals="-6">34860000000</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx8" xml:lang="en">Net profit</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx8" unitRef="vDKK" decimals="-6">26481000000</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx9" xml:lang="en">Non-recurring income from the partial divestment of NNIT A/S included in Other operating income</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx9" unitRef="vDKK" decimals="-6">0</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx10" xml:lang="en">Non-recurring income from the partial divestment of NNIT A/S included in Other operating income</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx10" unitRef="vDKK" decimals="-6">-2526000000</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx11" xml:lang="en">Non-recurring income from the partial divestment of NNIT A/S included in Other operating income</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx11" unitRef="vDKK" decimals="-6">0</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInInvestingActivities contextRef="ctx12" xml:lang="en">Sale of marketable securities</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInInvestingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInInvestingActivities contextRef="ctx12" unitRef="vDKK" decimals="-6">2064000000</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInInvestingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInInvestingActivities contextRef="ctx13" xml:lang="en">Sale of marketable securities</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInInvestingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInInvestingActivities contextRef="ctx13" unitRef="vDKK" decimals="-6">1500000000</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInInvestingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInInvestingActivities contextRef="ctx14" xml:lang="en">Sale of marketable securities</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInInvestingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInInvestingActivities contextRef="ctx14" unitRef="vDKK" decimals="-6">2232000000</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInInvestingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInInvestingActivities contextRef="ctx15" xml:lang="en">Purchase of marketable securities</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInInvestingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInInvestingActivities contextRef="ctx15" unitRef="vDKK" decimals="-6">-531000000</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInInvestingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInInvestingActivities contextRef="ctx16" xml:lang="en">Purchase of marketable securities</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInInvestingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInInvestingActivities contextRef="ctx16" unitRef="vDKK" decimals="-6">-3533000000</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInInvestingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInInvestingActivities contextRef="ctx17" xml:lang="en">Purchase of marketable securities</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInInvestingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInInvestingActivities contextRef="ctx17" unitRef="vDKK" decimals="-6">0</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInInvestingActivities>
<ifrs-full:CashAndCashEquivalents contextRef="ctx18" unitRef="vDKK" decimals="-6">15850000000</ifrs-full:CashAndCashEquivalents>
<ifrs-full:CashAndCashEquivalents contextRef="ctx19" unitRef="vDKK" decimals="-6">13676000000</ifrs-full:CashAndCashEquivalents>
<ifrs-full:CashAndCashEquivalents contextRef="ctx20" unitRef="vDKK" decimals="-6">10513000000</ifrs-full:CashAndCashEquivalents>
<ifrs-full:CashAndCashEquivalents contextRef="ctx21" unitRef="vDKK" decimals="-6">13676000000</ifrs-full:CashAndCashEquivalents>
<cmn:NameOfAuditFirm contextRef="ctx22" xml:lang="en">PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab</cmn:NameOfAuditFirm>
<cmn:IdentificationNumberCvrOfAuditFirm contextRef="ctx22">33771231</cmn:IdentificationNumberCvrOfAuditFirm>
<cmn:NameAndSurnameOfAuditor contextRef="ctx22" xml:lang="en">Mogens Nørgaard Mogensen</cmn:NameAndSurnameOfAuditor>
<cmn:DescriptionOfAuditor contextRef="ctx22" xml:lang="en">State Authorised Public Accountant</cmn:DescriptionOfAuditor>
<cmn:NameAndSurnameOfAuditor contextRef="ctx23" xml:lang="en">Torben Jensen</cmn:NameAndSurnameOfAuditor>
<cmn:DescriptionOfAuditor contextRef="ctx23" xml:lang="en">State Authorised Public Accountant</cmn:DescriptionOfAuditor>
<cmn:NameAndSurnameOfMemberOfExecutiveBoard contextRef="ctx24" xml:lang="en">Lars Fruergaard Jørgensen</cmn:NameAndSurnameOfMemberOfExecutiveBoard>
<cmn:TitleOfMemberOfExecutiveBoard contextRef="ctx24" xml:lang="en">President and CEO</cmn:TitleOfMemberOfExecutiveBoard>
<cmn:NameAndSurnameOfMemberOfExecutiveBoard contextRef="ctx25" xml:lang="en">Jesper Brandgaard</cmn:NameAndSurnameOfMemberOfExecutiveBoard>
<cmn:TitleOfMemberOfExecutiveBoard contextRef="ctx25" xml:lang="en">CFO</cmn:TitleOfMemberOfExecutiveBoard>
<cmn:NameAndSurnameOfMemberOfExecutiveBoard contextRef="ctx26" xml:lang="en">Mads Krogsgaard Thomsen</cmn:NameAndSurnameOfMemberOfExecutiveBoard>
<cmn:NameAndSurnameOfMemberOfExecutiveBoard contextRef="ctx27" xml:lang="en">Henrik Wulff</cmn:NameAndSurnameOfMemberOfExecutiveBoard>
<cmn:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="ctx28" xml:lang="en">Göran Ando</cmn:NameAndSurnameOfMemberOfSupervisoryBoard>
<cmn:TitleOfMemberOfSupervisoryBoard contextRef="ctx28" xml:lang="en">Chairman</cmn:TitleOfMemberOfSupervisoryBoard>
<cmn:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="ctx29" xml:lang="en">Jeppe Christiansen</cmn:NameAndSurnameOfMemberOfSupervisoryBoard>
<cmn:TitleOfMemberOfSupervisoryBoard contextRef="ctx29" xml:lang="en">Vice chairman</cmn:TitleOfMemberOfSupervisoryBoard>
<cmn:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="ctx30" xml:lang="en">Bruno Angelici</cmn:NameAndSurnameOfMemberOfSupervisoryBoard>
<cmn:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="ctx31" xml:lang="en">Brian Daniels</cmn:NameAndSurnameOfMemberOfSupervisoryBoard>
<cmn:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="ctx32" xml:lang="en">Sylvie Grégoire</cmn:NameAndSurnameOfMemberOfSupervisoryBoard>
<cmn:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="ctx33" xml:lang="en">Liz Hewitt</cmn:NameAndSurnameOfMemberOfSupervisoryBoard>
<cmn:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="ctx34" xml:lang="en">Liselotte Hyveled</cmn:NameAndSurnameOfMemberOfSupervisoryBoard>
<cmn:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="ctx35" xml:lang="en">Anne Marie Kverneland</cmn:NameAndSurnameOfMemberOfSupervisoryBoard>
<cmn:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="ctx36" xml:lang="en">Søren Thuesen Pedersen</cmn:NameAndSurnameOfMemberOfSupervisoryBoard>
<cmn:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="ctx37" xml:lang="en">Stig Strøbæk</cmn:NameAndSurnameOfMemberOfSupervisoryBoard>
<cmn:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="ctx38" xml:lang="en">Mary Szela</cmn:NameAndSurnameOfMemberOfSupervisoryBoard>
</xbrli:xbrl>